Literature DB >> 21527396

Cardiac involvement in nonketotic hyperglycinemia.

Ibraheem Al-Shareef1, Mariam Arabi, Omar Dabbagh.   

Abstract

Nonketotic hyperglycinemia is an autosomal recessive disorder of glycine metabolism characterized by the accumulation of glycine in the serum and cerebrospinal fluid with elevated cerebrospinal fluid to serum glycine ratio. The disease primarily affects the central nervous system, and has not been previously associated with myocardial involvement. In this article, the authors report an infant with nonketotic hyperglycinemia, who was found to have progressive left ventricular hypertrophy and dysfunction. His older sibling, who had a similar neurologic presentation, died of dilated cardiomyopathy as stated by the parents. The authors speculate that glycine may have a role in the development of cardiac dysfunction. The incidence of cardiac involvement may be under-diagnosed. They suggest the need for a cardiac evaluation in confirmed cases of nonketotic hyperglycinemia.

Entities:  

Mesh:

Year:  2011        PMID: 21527396     DOI: 10.1177/0883073811399150

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  4 in total

1.  Variant non ketotic hyperglycinemia is caused by mutations in LIAS, BOLA3 and the novel gene GLRX5.

Authors:  Peter R Baker; Marisa W Friederich; Michael A Swanson; Tamim Shaikh; Kaustuv Bhattacharya; Gunter H Scharer; Joseph Aicher; Geralyn Creadon-Swindell; Elizabeth Geiger; Kenneth N MacLean; Wang-Tso Lee; Charu Deshpande; Mary-Louise Freckmann; Ling-Yu Shih; Melissa Wasserstein; Malene B Rasmussen; Allan M Lund; Peter Procopis; Jessie M Cameron; Brian H Robinson; Garry K Brown; Ruth M Brown; Alison G Compton; Carol L Dieckmann; Renata Collard; Curtis R Coughlin; Elaine Spector; Michael F Wempe; Johan L K Van Hove
Journal:  Brain       Date:  2013-12-11       Impact factor: 13.501

2.  Lipoic acid synthetase deficiency causes neonatal-onset epilepsy, defective mitochondrial energy metabolism, and glycine elevation.

Authors:  Johannes A Mayr; Franz A Zimmermann; Christine Fauth; Christa Bergheim; David Meierhofer; Doris Radmayr; Johannes Zschocke; Johannes Koch; Wolfgang Sperl
Journal:  Am J Hum Genet       Date:  2011-12-09       Impact factor: 11.025

Review 3.  Nonketotic Hyperglycinemia: Insight into Current Therapies.

Authors:  Magdalena Nowak; Piotr Chuchra; Justyna Paprocka
Journal:  J Clin Med       Date:  2022-05-27       Impact factor: 4.964

4.  Musculoskeletal manifestations of neonatal nonketotic hyperglycinemia.

Authors:  Norman Ramirez; John M Flynn; Francisco Casalduc; Stephanie Rodriguez; Alberto S Cornier; Simón Carlo
Journal:  J Child Orthop       Date:  2012-05-25       Impact factor: 1.548

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.